Filing Impact
Filing Sentiment
Form Type
144
Candel Therapeutics, Inc.
327.17M
44.95M
16.76%
42.27%
12.9%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
NEEDHAM